Phytochem Remedies India IPO offers a mid-sized, profitable play in the specialty packaging / pharma-support segment, with steady growth and a capex-driven expansion roadmap.​

Phytochem Remedies IPO – Key Details

• Company: Phytochem Remedies India Limited
• Sector: Packaging / pharma-support solutions (corrugated / printed packaging-related business as inferred from peer set)
• IPO Type: SME IPO (book-built, fresh issue)
• IPO Open Date: 18 December 2025
• IPO Close Date: 22 December 2025
• Basis of Allotment: 23 December 2025
• Refunds / Demat Credit: 24 December 2025
• Listing Date: 26 December 2025 (SME platform)​
• Market Lot: 2,400 shares; minimum retail application = 2,400 shares worth ₹2,35,200
• Retail Max: 2,400 shares; S‑HNI: 3,600 shares (₹3,52,800) and above​
• Promoters: Aditi Bohra, Bohra Agrifilms Pvt. Ltd., Niranjan Surana, Shilpa Surana
• Promoter Holding: 100% pre‑issue (78,75,000 shares); 66.88% post‑issue (1,17,75,000 shares)
• Lead Manager: Mefcom Capital Markets Ltd.; Registrar: Bigshare Services Pvt. Ltd.​

Business & Financial Snapshot

• Phytochem Remedies operates in manufacturing/packaging linked to pharma / FMCG supply chains (as indicated by packaging peers), with products supporting branded goods and rising organised packaging demand.​

Financials (₹ in crore):​

Phytochem Remedies (India) Ltd.'s revenue increased by 12% and profit after tax (PAT) rose by 94% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended	30 Sep 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	53.68	44.50	41.85	37.07
Total Income	25.01	36.81	32.90	20.83
Profit After Tax	3.75	4.48	2.31	0.82
EBITDA	6.72	8.69	5.88	2.91
NET Worth	16.89	13.14	8.74	6.42
Reserves and Surplus	9.02	9.99	5.51	3.20
Total Borrowing	19.32	18.69	21.02	20.30
Amount in ₹ Crore

Objective of the Issue (₹ crore):​

• Equipment/machinery capex: ₹13.60

• Civil construction capex: ₹5.88
• Debt repayment / pre‑payment: ₹9.37
• General corporate purposes: ₹5.64

IPO Reservation

Phytochem Remedies IPO offers total 39,00,000 shares. Out of which 18,51,600 (47.48%) allocated to NII 18,51,600 (47.48%) allocated to RII.

IPO Lot Size

Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Key Strengths

• Consistent revenue and PAT growth FY23–FY25

• High ROE (~34%) and healthy ROCE (~25%)
• Strong EBITDA and PAT margins for packaging-type business
• Attractive P/E valuation (~6.9x) vs listed packaging peers
• Clear capex plan for machinery and civil expansion
• Promoters retaining significant 66.88% stake post‑issue

Key Risks

• Elevated leverage (debt–equity 1.42) despite repayment plan
• Modest absolute scale of revenue (₹36–37 crore in FY25)
• Working-capital intensive nature of packaging/industrial supply
• Client concentration and demand cyclicality risk
• SME listing with high minimum ticket (₹2.35 lakh) and lower liquidity
• Execution risk around new capex and capacity utilisation

FAQs

Q1. What are the Phytochem Remedies IPO dates and listing schedule?

• Opens on 18 December 2025 and closes on 22 December 2025. Basis of allotment is on 23 December; refunds and Demat credit on 24 December; listing on 26 December 2025.​

Q2. What is the lot size and minimum investment for retail investors?

• Minimum lot size is 2,400 shares; minimum retail application amount is ₹2,35,200.​

Q3. How is the issue reserved across investor categories?

• NII: 18,51,600 shares (47.48%); Retail: 18,51,600 shares (47.48%); balance for other categories as per SME norms.​

Q4. How will the IPO proceeds be utilised?

• For plant/machinery capex (₹13.60 crore), civil construction (₹5.88 crore), debt repayment (₹9.37 crore) and general corporate purposes (₹5.64 crore).​

Q5. How has Phytochem Remedies performed financially?

• Revenue grew from ₹20.83 crore (FY23) to ₹36.81 crore (FY25); PAT increased from ₹0.82 crore to ₹4.48 crore, with FY25 ROE at 34.07% and PAT margin at 12.25%.​

Q6. Who are the listed peers for comparison?

• Perfectpac Ltd, Worth Peripherals Ltd and GKP Printing & Packaging Ltd are cited as comparable companies in the packaging/printing space.​